Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemed Corp (NY:CHE)

435.53 -1.09 (-0.25%)
Streaming Delayed Price Updated: 12:43 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemed Corp

< Previous 1 2 3 4 5 6 7 8 9 Next >
Chemed (CHE) Q3 Earnings: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be announcing earnings results this Tuesday after market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
1 Cash-Producing Stock with Competitive Advantages and 2 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
3 Reasons CHE is Risky and 1 Stock to Buy Instead
Chemed has gotten torched over the last six months - since April 2025, its stock price has dropped 23.7% to $436.07 per share. This was partly driven by its softer quarterly results and might have... 
Via StockStory
Chemed To Report Third-Quarter 2025 Earnings October 28, Related Conference Call To Be Held On October 29
From Chemed Corporation
Via Business Wire
Analyst Expectations For Chemed's Future
 
Via Benzinga
Earnings Scheduled For July 29, 2025
 
Via Benzinga
Earnings Preview For Chemed
 
Via Benzinga
Chemed Corporation to Present at the Jefferies 2025 Healthcare Services Conference
From Chemed Corporation
Via Business Wire
3 Recession-Ready Stocks That Thrive When the Economy Sputters
These three companies offer different defensive strengths that could benefit investors looking to insulate themselves from a potential recession. 
Via MarketBeat
Topics Economy Energy
3 Profitable Stocks with Warning Signs
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Looking Into Chemed's Recent Short Interest
 
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Chemed
 
Via Benzinga
Why Chemed (CHE) Stock Is Up Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) jumped 1.2% in the afternoon session after the company received a stock rating upgrade from financial services firm Jefferies. 
Via StockStory
Topics Artificial Intelligence
Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
This Zscaler Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday
 
Via Benzinga
3 Healthcare Stocks with Open Questions
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
3 Low-Volatility Stocks That Concern Us
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
1 Cash-Producing Stock to Target This Week and 2 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
CHE Q2 Deep Dive: Margin Pressure, Medicare Cap Challenges, and Strategic Repositioning
Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $618.8 million. Its non-GAAP profit of $4.27 per share... 
Via StockStory
Q2 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at senior health, home health & hospice... 
Via StockStory
Topics Economy
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
From Chemed Corporation
Via Business Wire
Here's How Much $100 Invested In Chemed 15 Years Ago Would Be Worth Today
 
Via Benzinga
VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer
From VITAS Healthcare
Via GlobeNewswire
Why Chemed Stock Is Plummeting Today
Chemed missed expectations on both the top and bottom lines with its second-quarter earnings. 
Via The Motley Fool
Topics Earnings
Why Chemed (CHE) Stock Is Trading Lower Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 9% in the afternoon session after the company reported disappointing second-quarter results which missed analysts' EPS and... 
Via StockStory
Chemed’s (NYSE:CHE) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops
Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $618.8 million. Its non-GAAP profit of $4.27 per share... 
Via StockStory
Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure
From Chemed Corporation
Via Business Wire
Chemed (CHE) Q2 Earnings: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results this Tuesday after market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.